Verification of EZH2 as a druggable target in metastatic uveal melanoma

MLA

Huasheng Yang, et al. “Verification of EZH2 as a Druggable Target in Metastatic Uveal Melanoma.” Molecular Cancer, vol. 19, Mar. 2020. EBSCOhost, https://doi.org/10.1186/s12943-020-01173-x.

APA

Huasheng Yang, Jingxuan Pan, Yun Wang, Ping Zhang, Jing Zhang, Huijing Ye, Hailin Zou, & Bei Jin. (2020). Verification of EZH2 as a druggable target in metastatic uveal melanoma. Molecular Cancer, 19. https://doi.org/10.1186/s12943-020-01173-x

Chicago

Huasheng Yang, Jingxuan Pan, Yun Wang, Ping Zhang, Jing Zhang, Huijing Ye, Hailin Zou, and Bei Jin. 2020. “Verification of EZH2 as a Druggable Target in Metastatic Uveal Melanoma.” Molecular Cancer 19 (March). doi:10.1186/s12943-020-01173-x.